fluindione has been researched along with Auricular Fibrillation in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Berland, M; Charuel, E; Giron, A; Lambert, C; Ménini, T; Pereira, B; Poinas, L; Schmidt, J; Vorilhon, P | 1 |
| Anderson, R; Baber, U; Boersma, E; Capranzano, P; Chen, C; Dangas, GD; Duggal, A; Hambrecht, R; Hayashida, K; Hengstenberg, C; Jin, J; Kim, HS; Laeis, P; Lang, I; Lanz, H; López-Otero, D; Mehran, R; Meincke, F; Möllmann, H; Moreno, R; Nombela-Franco, L; Nordbeck, P; Ohlmann, P; Pilgrim, T; Rodés-Cabau, J; Saito, S; Shawl, F; Thiele, H; Unverdorben, M; Valgimigli, M; Van Mieghem, NM; Veltkamp, R; Vranckx, P; Watanabe, Y; Yamamoto, M; Zamorano, JL | 1 |
| Bonello, L; Camoin-Jau, L; Gaubert, M; Laine, M; Paganelli, F; Resseguier, N | 1 |
| Caré, B; Laroche, JP; Quéré, I; Schved, JF; Valdelièvre, E | 1 |
| Feutry, F; Marliot, G; Pannier, D; Strobbe, G; Villain, A | 1 |
| Ammentorp, B; Darius, H; De Caterina, R; Kirchhof, P; Le Heuzey, JY; Schilling, RJ; Schmitt, J; Zamorano, JL | 1 |
| Annweiler, C; Barberger-Gateau, P; Beauchet, O; Brangier, A; Ferland, G; Rolland, Y | 1 |
| Cordeanu, EM; Gaertner, S; Mirea, C; Stephan, D | 1 |
| Bertrand, M; Blotière, PO; Bouillon, K; Maura, G; Ricordeau, P; Zureik, M | 1 |
| Daugas, E; Grimaldi, D; Mougenot, B; Ronco, P; Rossert, J | 1 |
| Ansell, J; Caro, J; Drouet, L; Hollowell, J; Martinez-Brotons, F; Pengo, V | 1 |
| Algayres, JP; Béchade, D; Daly, JP; Henrionnet, A | 1 |
| Chaumet-Riffaud, P; Derumeaux, G; Lacomblez, L; Lardoux, H; Lechat, P; Lecompte, T; Maillard, L; Mallet, A; Mas, JL; Mentre, F; Pisica, G; Pousset, F; Raynaud, P; Sanchez, P; Solbes-Latourette, S | 1 |
2 trial(s) available for fluindione and Auricular Fibrillation
| Article | Year |
|---|---|
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Topics: 4-Hydroxycoumarins; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Mortality; Phenindione; Postoperative Complications; Pyridines; Thiazoles; Thromboembolism; Transcatheter Aortic Valve Replacement; Vitamin K | 2021 |
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Hemorrhage; Humans; Male; Phenindione; Risk Factors; Thromboembolism; Treatment Outcome; Vascular Diseases | 2001 |
11 other study(ies) available for fluindione and Auricular Fibrillation
| Article | Year |
|---|---|
[Comparative study in primary care of the stability of INR in patients treated with warfarin or fluindione for atrial fibrillation. The FLOWER study (FLuindione Or WarfarinE - Result INR)].
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Flowers; Hemorrhage; Humans; International Normalized Ratio; Phenindione; Primary Health Care; Retrospective Studies; Stroke; Warfarin | 2022 |
Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation.
Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Angiography; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Incidence; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Patient Safety; Phenindione; Propensity Score; Proportional Hazards Models; Risk; Treatment Outcome; Vitamin K | 2018 |
[Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
Topics: Acenocoumarol; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Female; Humans; International Normalized Ratio; Male; Middle Aged; Phenindione; Risk Factors; Sex Factors; Thromboembolism; Treatment Outcome; Vitamin K; Warfarin | 2018 |
First-time prescription of enzalutamide in a patient treated with fluindione and digoxin: serial drug interactions.
Topics: Aged; Atrial Fibrillation; Benzamides; Digoxin; Drug Interactions; Drug Overdose; Drug Substitution; Hematemesis; Humans; International Normalized Ratio; Male; Nitriles; Phenindione; Phenylthiohydantoin; Polypharmacy; Prostatic Neoplasms; Tinzaparin | 2019 |
Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Europe; Female; Humans; Male; Middle Aged; Phenindione; Phenprocoumon; Practice Guidelines as Topic; Registries; Vitamin K; Warfarin; Withholding Treatment | 2014 |
Vitamin K antagonists and cognitive impairment: results from a cross-sectional pilot study among geriatric patients.
Topics: Aged; Aged, 80 and over; Aging; Anticoagulants; Atrial Fibrillation; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Male; Mental Status Schedule; Phenindione; Pilot Projects; Risk Factors; Stroke; Vitamin K | 2015 |
Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Electrocardiography; Factor Xa Inhibitors; Female; Humans; Phenindione; Rivaroxaban; Thrombosis; Vitamin K | 2015 |
Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
Topics: Acenocoumarol; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Male; Phenindione; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Thromboembolism; Vitamin K; Warfarin | 2015 |
Immuno-allergic interstitial nephritis related to fluindione: first biopsy proven cases.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Atrial Fibrillation; Biopsy, Needle; Female; Follow-Up Studies; Humans; Immunohistochemistry; Kidney Function Tests; Male; Nephritis, Interstitial; Phenindione; Risk Assessment; Severity of Illness Index | 2006 |
Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Canada; Cohort Studies; Drug Monitoring; Female; France; Humans; International Normalized Ratio; Italy; Male; Middle Aged; Phenindione; Practice Patterns, Physicians'; Quality of Health Care; Retrospective Studies; Spain; Stroke; Treatment Outcome; United States; Warfarin | 2007 |
[Analysis of a circulating anticoagulant in the course of treatment with an antivitamin K. Importance in a febrile patient].
Topics: Acebutolol; Aged; Anti-Arrhythmia Agents; Antibodies, Antiphospholipid; Anticoagulants; Atrial Fibrillation; Digoxin; Fever of Unknown Origin; Humans; Immunoglobulins; Lupus Coagulation Inhibitor; Male; Phenindione; Q Fever | 2000 |